IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SIMONE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.832
NA - Nord America 2.466
AS - Asia 1.252
AF - Africa 32
SA - Sud America 27
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.633
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.337
GB - Regno Unito 1.181
CN - Cina 509
SG - Singapore 370
IT - Italia 361
SE - Svezia 326
DE - Germania 319
RU - Federazione Russa 142
FI - Finlandia 131
CA - Canada 123
KR - Corea 105
IE - Irlanda 77
HK - Hong Kong 75
FR - Francia 62
IN - India 58
TR - Turchia 49
UA - Ucraina 49
DK - Danimarca 42
EU - Europa 40
BE - Belgio 32
NG - Nigeria 28
PL - Polonia 28
NL - Olanda 27
ID - Indonesia 24
JP - Giappone 23
AU - Australia 17
CO - Colombia 14
TW - Taiwan 13
ES - Italia 12
CZ - Repubblica Ceca 9
BR - Brasile 8
VN - Vietnam 8
GR - Grecia 7
AT - Austria 6
IL - Israele 6
RO - Romania 6
BG - Bulgaria 5
CI - Costa d'Avorio 4
NZ - Nuova Zelanda 4
CH - Svizzera 3
CL - Cile 3
MX - Messico 3
HN - Honduras 2
MD - Moldavia 2
MY - Malesia 2
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
GL - Groenlandia 1
HR - Croazia 1
IR - Iran 1
PE - Perù 1
SA - Arabia Saudita 1
Totale 6.671
Salva come PNG Salva come JPEG
Città #
Southend 1.087
Chandler 331
Singapore 285
Houston 177
Ashburn 170
Fairfield 164
Wilmington 157
Seattle 143
Milan 132
Ann Arbor 117
Princeton 113
Woodbridge 102
Toronto 100
Beijing 86
Helsinki 79
Dublin 75
Hong Kong 63
Nanjing 46
Phoenix 43
Cambridge 38
Grafing 38
Mountain View 37
Redmond 36
Shanghai 36
Bengaluru 32
Boardman 32
Des Moines 31
Santa Clara 30
Dearborn 29
Lekki 28
Warsaw 28
Jinan 27
Brussels 25
Shenyang 25
Somerville 23
Hangzhou 21
Redwood City 21
Guangzhou 20
Jakarta 20
Bitonto 19
Sakarya 19
New York 18
Norwalk 18
Andover 17
Frankfurt am Main 17
Ottawa 17
Seongnam 17
Medford 15
Bogotá 14
Kiez 14
Nanchang 14
Eitensheim 13
Fuzhou 13
Changsha 12
Jacksonville 12
Hebei 11
Ningbo 11
Serra 11
Zhengzhou 11
Hamburg 10
Quanzhou 10
Roxbury 10
San Diego 10
Taipei 10
Brno 9
Los Angeles 9
Silver Spring 9
Hanover 8
Falls Church 7
Rome 7
Seoul 7
Tianjin 7
Athens 6
North Bergen 6
Taizhou 6
Wako 6
Berlin 5
Bridge 5
Cagliari 5
Columbia 5
Durham 5
Mumbai 5
Piscataway 5
Suwon 5
Tel Aviv 5
Tokyo 5
Wuhan 5
Abidjan 4
Bogen 4
Catania 4
Central 4
Chicago 4
Dong Ket 4
Florence 4
Fremont 4
Huntington Station 4
Kilburn 4
Las Vegas 4
Margão 4
Munich 4
Totale 4.584
Salva come PNG Salva come JPEG
Nome #
GENERAZIONE E CORREZIONE DI CELLULE STAMINALIPLURIPOTENTI INDOTTE NON VIRALI DA PAZIENTE SMA COMEMODELLO DI MALATTIA E SORGENTE PER LA TERAPIA CELLULARE 336
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model 331
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 252
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches 251
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 245
IPSC-derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1 213
Direct reprogramming of adult somatic cells into other lineages: past evidence and future perspectives 203
Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives 196
Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS 187
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype 183
Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications? 180
Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS 167
ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development 161
Therapeutic Development in Amyotrophic Lateral Sclerosis 151
Embryonic stem cell–derived neural stem cells improve spinal muscular atrophy phenotype in mice 150
Direct reprogramming of human astrocytes into neural stem cells and neurons 146
Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy 141
Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases 141
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 139
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 135
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 128
Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA) 118
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 113
Neuroprotection in spinal muscular atrophy (SMA) using neural stem cells as a therapeuthic approach 113
Pluripotent engineered stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice 112
Neural stem cells derived from genetically engineered lineage-selectable Es cells improves the phenotype of a mouse model of spinal muscular atrophy 111
Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells 111
Genetic correction of spinal muscular atrophy-induced pluripotent stem cells and motoneurons as a disease model and cell source for transplantation 110
A model for motor neuron degeneration and treatment of Spinal Muscular Atrophy using human induced pluripotent stem cells 110
Beta-lactam antibiotic offer neuroprotection in a spinal muscular atrophy mouse model by multiple mechanisms 109
Development of a therapeutic approach for Spinal Muscular Atrophy with Respiratory Distress (SMARD1) using human induced pluripotent stem cell-derived neural stem cells and motor neurons 109
Directing human astrocytes into neural stem cells and neurons as possible tool for repair in CNS diseases 108
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis 106
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis 106
Beta lactam antibiotic ameliorates spinal muscular atrophy phenotype in a mouse model by multiple mechanisms 104
Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis 104
Motor neurons from human spinal muscular atrophy–induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 104
Targeted gene correction of spinal muscular atrophy induced pluripotent stem cells and motoneurons as cell source for therapy 101
Motoneurons from human spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 101
Transplantation of neural stem cells derived from genetically engineered, lineage-selectable ES cells improves spinal muscular atrophy 100
Gene Corrected Spinal Muscular Atrophy-Induced Pluripotent Stem Cells and Motoneuron as a Model and Cell Source for Transplantation (IN8-2.002) 99
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 98
Molecular therapeutic strategies for spinal muscular atrophies : Current and future clinical trials 98
Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy δ7 mouse model phenotype 96
MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives 95
Pluripotent stem cell-based models of spinal muscular atrophy 93
Systemic transplantation of c-kit+ cells can ameliorate the phenotype of a mouse model of Amyotrophic Lateral Sclerosis 88
Generation of motoneurons from spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences : in vitro and In vivo analysis 83
Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation 80
The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review 80
In vitro and in vivo analysis of motoneurons obtained from human-spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences 76
null 4
null 3
null 3
null 3
null 3
null 3
null 3
null 3
null 3
null 3
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 1
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 1
Totale 7.105
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020518 0 0 0 0 0 0 56 95 181 114 51 21
2020/2021695 33 31 49 20 62 60 85 60 79 33 114 69
2021/2022766 45 64 24 47 40 54 39 25 127 86 62 153
2022/2023934 124 124 85 107 110 153 26 52 108 12 25 8
2023/2024633 21 38 36 68 149 68 21 33 25 33 55 86
2024/2025622 66 131 72 188 100 62 3 0 0 0 0 0
Totale 7.105